Future Research on and Implementaion of the Bergen 4-Day Treatment - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Future Directions for Research and Implementation of the Bergen 4-Day Treatment for OCD

  • By

  • Eric A. Storch

  • Caitlin M. Pinciotti

  • October 19, 2026

Share

  • 1

    In a randomized trial of 119 adults with OCD, the Bergen 4-Day Treatment (B4DT) outperformed unguided internet-based cognitive behavioral therapy, with a large effect size (g = −1.6).

  • 2

    At 3-month follow-up, B4DT response and remission rates were 61.4% and 42.1%, respectively, compared with 25% and 13.6% for internet-based therapy.

  • 3

    Future trials should compare B4DT with an equivalent dose of active exposure and response prevention delivered over a longer period.

  • 4

    Only 119 of 253 screened adults entered the trial; future research should report screening and exclusion reasons and study clinically diverse samples in naturalistic settings.

  • 5

    The B4DT’s place in care and its accessibility remain uncertain, warranting rigorous control conditions and broad international replication across patients with differing motivation and engagement.

Original Source(s)

Related Content